Complement activation during rejection in experimental intestinal transplantation.
Soin
A S
AS
Transplant Unit, University of Cambridge Clinical School, Addenbrooke's Hospital, United Kingdom.
Pino-Chavez
G
G
Chavez-Cartaya
R
R
Jamieson
N V
NV
White
D J
DJ
Friend
P J
PJ
D000818:Animals; D003167:Complement Activation; D003176:Complement C3 / Q000032:analysis; D003186:Complement C9 / Q000032:analysis; D004546:Elapid Venoms / Q000494:pharmacology; D006084:Graft Rejection / Q000276:immunology* / Q000517:prevention & control; D006085:Graft Survival / Q000276:immunology; D007421:Intestine, Small / Q000276:immunology / Q000473:pathology / Q000637:transplantation*; D008297:Male; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000494:pharmacology; D014184:Transplantation, Homologous / Q000276:immunology*
D003176:Complement C3; D003186:Complement C9; D004546:Elapid Venoms; C016310:cobra venom factor; D016559:Tacrolimus